These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

877 related items for PubMed ID: 14560344

  • 21. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Curtis AB, Gersh BJ, Corley SD, DiMarco JP, Domanski MJ, Geller N, Greene HL, Kellen JC, Mickel M, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG, AFFIRM Investigators.
    Am Heart J; 2005 Apr; 149(4):645-9. PubMed ID: 15990747
    [Abstract] [Full Text] [Related]

  • 22. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
    Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ, Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group.
    N Engl J Med; 2002 Dec 05; 347(23):1834-40. PubMed ID: 12466507
    [Abstract] [Full Text] [Related]

  • 23. Immediate recurrence of atrial fibrillation after internal cardioversion: importance of right atrial conduction variations.
    Gorenek B, Kudaiberdieva G, Cavusoglu Y, Goktekin O, Birdane A, Unalir A, Ata N, Timuralp B.
    J Electrocardiol; 2002 Oct 05; 35(4):313-20. PubMed ID: 12395358
    [Abstract] [Full Text] [Related]

  • 24. n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study.
    Bianconi L, Calò L, Mennuni M, Santini L, Morosetti P, Azzolini P, Barbato G, Biscione F, Romano P, Santini M.
    Europace; 2011 Feb 05; 13(2):174-81. PubMed ID: 21059740
    [Abstract] [Full Text] [Related]

  • 25. Management of atrial fibrillation in the elderly.
    Aronow WS.
    Minerva Med; 2009 Feb 05; 100(1):3-24. PubMed ID: 19182738
    [Abstract] [Full Text] [Related]

  • 26. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
    Naegeli B, Straumann E, Bertel O.
    Int J Cardiol; 2005 Mar 18; 99(2):283-7. PubMed ID: 15749188
    [Abstract] [Full Text] [Related]

  • 27. A decrease of enlarged left atrium following cardioversion of atrial fibrillation predicts the long-term maintenance of sinus rhythm.
    Kosior DA, Szulc M, Torbicki A, Opolski G, Rabczenko D.
    Kardiol Pol; 2005 May 18; 62(5):428-37; discussion 438-9. PubMed ID: 15928720
    [Abstract] [Full Text] [Related]

  • 28. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study.
    Rienstra M, Van Veldhuisen DJ, Hagens VE, Ranchor AV, Veeger NJ, Crijns HJ, Van Gelder IC, RACE Investigators.
    J Am Coll Cardiol; 2005 Oct 04; 46(7):1298-306. PubMed ID: 16198847
    [Abstract] [Full Text] [Related]

  • 29. Single dose of ibutilide for conversion of persistent atrial fibrillation after radiofrequency ablation.
    Hou Y, Fang PH, Liu J, Li XF, Hu JQ, Zhang S.
    Chin Med J (Engl); 2011 Mar 04; 124(5):710-3. PubMed ID: 21518563
    [Abstract] [Full Text] [Related]

  • 30. The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion.
    Celebi OO, Celebi S, Canbay A, Ergun G, Aydogdu S, Diker E.
    Cardiology; 2011 Mar 04; 118(3):168-74. PubMed ID: 21654170
    [Abstract] [Full Text] [Related]

  • 31. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL, Connolly SJ, Crijns HJ, van Eickels M, Gaudin C, Torp-Pedersen C, Hohnloser SH, ATHENA Investigators.
    Am J Cardiol; 2011 Apr 01; 107(7):1019-22. PubMed ID: 21296333
    [Abstract] [Full Text] [Related]

  • 32. Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs.
    Schilling RJ.
    Heart; 2010 Mar 01; 96(5):333-8. PubMed ID: 19910286
    [Abstract] [Full Text] [Related]

  • 33. Effect of restoration of sinus rhythm by extensive antiarrhythmic drugs in predicting results of catheter ablation of persistent atrial fibrillation.
    Igarashi M, Tada H, Sekiguchi Y, Yamasaki H, Arimoto T, Kuroki K, Machino T, Murakoshi N, Aonuma K.
    Am J Cardiol; 2010 Jul 01; 106(1):62-8. PubMed ID: 20609649
    [Abstract] [Full Text] [Related]

  • 34. Comparison of rate control and rhythm control in patients with atrial fibrillation after percutaneous mitral balloon valvotomy: a randomised controlled study.
    Hu CL, Jiang H, Tang QZ, Zhang QH, Chen JB, Huang CX, Li GS.
    Heart; 2006 Aug 01; 92(8):1096-101. PubMed ID: 16387819
    [Abstract] [Full Text] [Related]

  • 35. Cardioversion of acute atrial fibrillation in the short observation unit: comparison of a protocol focused on electrical cardioversion with simple antiarrhythmic treatment.
    Cristoni L, Tampieri A, Mucci F, Iannone P, Venturi A, Cavazza M, Lenzi T.
    Emerg Med J; 2011 Nov 01; 28(11):932-7. PubMed ID: 20947916
    [Abstract] [Full Text] [Related]

  • 36. Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapy.
    Demir K, Can I, Koc F, Vatankulu MA, Ayhan S, Akilli H, Aribas A, Alihanoglu Y, Altunkeser BB.
    Med Princ Pract; 2011 Nov 01; 20(5):464-9. PubMed ID: 21757938
    [Abstract] [Full Text] [Related]

  • 37. Effectiveness of amiodarone versus bepridil in achieving conversion to sinus rhythm in patients with persistent atrial fibrillation: a randomised trial.
    Yamase M, Nakazato Y, Daida H.
    Heart; 2012 Jul 01; 98(14):1067-71. PubMed ID: 22689712
    [Abstract] [Full Text] [Related]

  • 38. Prediction of sinus rhythm maintenance following DC-cardioversion of persistent atrial fibrillation - the role of atrial cycle length.
    Meurling CJ, Roijer A, Waktare JE, Holmqvist F, Lindholm CJ, Ingemansson MP, Carlson J, Stridh M, Sörnmo L, Olsson SB.
    BMC Cardiovasc Disord; 2006 Mar 13; 6():11. PubMed ID: 16533393
    [Abstract] [Full Text] [Related]

  • 39. Baseline characteristics of patients from Poland enrolled in the global registry of patients with recently diagnosed atrial fibrillation (RecordAF).
    Opolski G, Kosior DA, Kurzelewski M, Skrzyńska M, Zagórski A, Janion M, Muzolf M, Wlazłowski R, Pankiewicz B, Łoboz-Grudzień K, Breithardt G, Polish RecordAF.
    Kardiol Pol; 2010 May 13; 68(5):546-54. PubMed ID: 20491018
    [Abstract] [Full Text] [Related]

  • 40. Role of oral amiodarone in patients with atrial fibrillation and congestive heart failure.
    Kawabata M, Hirao K, Hachiya H, Higuchi K, Tanaka Y, Yagishita A, Inaba O, Isobe M.
    J Cardiol; 2011 Sep 13; 58(2):108-15. PubMed ID: 21831597
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.